Emblem Corp EMMBF

Who/what is Aleafia Health Inc?

[CliffyCool]

Aleafia Health Inc. (OTCQX: ALEAF) is uniquely differentiated as a medical cannabis company as the interaction between the business and patient does not end at the point of sale. Aleafia Labs, a division of Aleafia Health Inc. and Guided 420 Genetics Inc. with U.S.-based AKESOgen, Inc., together have recently announced the commencement of a joint study on cannabinoid pharmacogenetics in medical cannabis therapy. The initial 200 patient study will focus on developing medical cannabis patient genetic screening tools in the areas of THC-CBD sensitivity and metabolism, Endocannabinoid Deficiency Syndrome and cannabis treatment safety and adverse event risk. This initiative will be funded by G420 and will be administered by Aleafia physicians practicing within the Canabo Medical Clinic network. The Study is expected to generate unique intellectual property assets that can be used towards proprietary product development and tools to improve medical cannabis treatment of major illnesses. It is expected that this study will lead to additional clinical investigations and larger retrospective cohort studies as well as prospective clinical trials based on the indications generated. "Aleafia is pleased to partner with G420/AKESOgen in a first of its kind cannabis related pharmacogenomics study," said Aleafia President of Clinic Operations, Dr. Gary Goodyear. "Aleafia's unique medical cannabis clinic business perfectly complements a robust clinical research strategy that should yield benefits to patients through the form of improved treatment methods and product development."